Oxidative damage in cerebral vessels of diabetic db/db mice

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 6, 2005, Pages 554-559

  Liao, Y J ^a,b   Ueno, M ^b   Nakagawa, T ^b   Huang, C ^b   Kanenishi, K ^b   Onodera, M ^b   Sakamoto, H ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Cerebral vessels; db db mice; Diabetes; Glycocalyx; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FERRITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN MICROCIRCULATION; CEREBROVASCULAR DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE EXPRESSION; GLYCOCALYX; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULARIZATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; DNA DAMAGE; GLYCOCALYX; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, MUTANT STRAINS; MICROCIRCULATION; MICROSCOPY, ELECTRON; OXIDATIVE STRESS;

EID: 27844579670     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.579     Document Type: Article

References (33)

1. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
2. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
3. Wiseman H, Kaur H, Halliwell B. DNA damage and cancer: measurement and mechanism. Cancer Lett 1995; 93: 113-120.
4. Ha H, Kim C, Son Y, Chung MH, Kim KH. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 1994; 16: 271-274.
5. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003; 284: F1138-F1144.
6. Laight DW, Carrier MJ, Anggard EE. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 1999; 15: 274-282.
7. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-1988.
8. Lee SM, Bressler R. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 1981; 31: 249-254.
9. Igel M, Kainulainen H, Brauers A, Becker W, Herberg L, Joost H-G. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawly rats) and obese (db/db mice, fa/fa rats) rodents. Diabetologia 1996; 39: 758-765.
10. Nishina PM, Lowe S, Wang J, Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 549-553.
11. Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxyguanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003; 26: 1507-1512.
12. Piconil L, Quagliarol L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003; 41: 1144-1149.
13. Collins AR, Raslova K, Somorovska M, et al. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med 1998; 25: 373-377.
14. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 1999; 42: 995-998.
15. Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91: 327-329.
16. Qin X, Zhang S, Nakatsuru Y, et al. Detection of active UV-photoproduct repair in monkey skin in vivo by quantitative immunohistochemistry. Cancer Lett 1994; 83: 291-298.
17. Hattori Y, Nishigori C, Tanaka T, et al. 8-hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol 1997; 107: 733-737.
18. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996; 74: 819-825.
19. Stauber WT, Ong SH, McCuskey RS. Selective extravascular escape of albumin into the cerebral cortex of the diabetic rat. Diabetes 1981; 30: 500-503.
20. Lorenzi M, Healy DP, Hawkins R, Printz JM, Printz MP. Studies on the permeability of the blood-brain barrier in experimental diabetes. Diabetologia 1986; 29: 58-62.
21. Rechthand E, Smith QR, Latker CH, Rapoport SI. Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus. J Neuropathol Exp Neurol 1987; 46: 302-314.
22. Lindner JR, Ismail S, Spotnitz WD, Skyba DM, Jayaweera AR, Kaul S. Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation 1998; 98: 2187-2194.
23. Ueno M, Sakamoto H, Tomimoto H, et al. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol 2004; 107: 532-538.
24. Reese TS, Karnovsky MJ. Fine structural localization of blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34: 207-217.
25. Ueno M, Akiguchi I, Hosokawa M, Kotani H, Kanenishi K, Sakamoto H. Blood-brain barrier permeability in the periventricular areas of the normal mouse brain. Acta Neuropathol 2000; 99: 385-392.
26. Thurauf N, Dermietzel R, Kalweit P. Surface charges associated with fenestrated brain capillaries. I. In vitro labeling of anionic sites. J Utrastruct Res 1983; 84: 103-110.
27. Vorbrodt AW, Lossinsky AS, Dobrogowska DH, Wisniewski HM. Distribution of anionic sites and glycoconjugates on the endothelial surfaces of the developing blood-brain barrier. Dev Brain Res 1986; 29: 69-79.
28. Won MH, Kang T-C, Jeon G-S, et al. Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo. Brain Res 1999; 836: 70-78.
29. Fox JG, Quin JD, Paterson KR, O'Reilly DS, Smith MP, Boulton-Jones JM. Glomerular charge selectivity in type I (insulin-dependent) diabetes mellitus. Diabet Med 1995; 12: 387-391.
30. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. Faseb J 1999; 13: 1231-1238.
31. Schafer K, Halle M, Goeschen C, et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004; 24: 112-117.
32. Sundell J, Huupponen R, Raitakari OT, Nuutila P, Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 2003; 11: 776-782.
33. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1-10.